132 related articles for article (PubMed ID: 2905249)
1. A pharmacokinetic study of roxatidine acetate in chronic renal failure.
Lameire N; Rosenkranz B; Maass L; Brockmeier D
Drugs; 1988; 35 Suppl 3():48-52. PubMed ID: 2905249
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of histamine (H2)-receptor antagonists, including roxatidine, in chronic renal failure.
Lameire N; Rosenkranz B; Brockmeier D
Scand J Gastroenterol Suppl; 1988; 146():100-10. PubMed ID: 2906455
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of roxatidine in patients with renal insufficiency.
Gladziwa U; Wagner S; Sieberth HG; Klotz U
Br J Clin Pharmacol; 1995 Feb; 39(2):161-7. PubMed ID: 7742154
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of roxatidine acetate in patients with chronic liver disease.
Tsutsumi M; Ueshima Y; Takase S
J Gastroenterol Hepatol; 2001 Aug; 16(8):910-5. PubMed ID: 11555106
[TBL] [Abstract][Full Text] [Related]
5. Famotidine disposition in children and adolescents with chronic renal insufficiency.
Maples HD; James LP; Stowe CD; Jones DP; Hak EB; Blumer JL; Vogt B; Wilson JT; Kearns GL; Wells TG;
J Clin Pharmacol; 2003 Jan; 43(1):7-14. PubMed ID: 12520622
[TBL] [Abstract][Full Text] [Related]
6. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Matzke GR; Abraham PA; Halstenson CE; Keane WF
Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
[TBL] [Abstract][Full Text] [Related]
7. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of roxatidine in healthy volunteers.
Collins JD; Pidgen AW
Drugs; 1988; 35 Suppl 3():41-7. PubMed ID: 2905248
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic characteristics of roxatidine.
Bender W; Brockmeier D
J Clin Gastroenterol; 1989; 11 Suppl 1():S6-19. PubMed ID: 2572622
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of clodronate in renal failure.
Saha H; Castren-Kortekangas P; Ojanen S; Juhakoski A; Tuominen J; Tokola O; Pasternack A
J Bone Miner Res; 1994 Dec; 9(12):1953-8. PubMed ID: 7872061
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function.
Takabatake T; Ohta H; Maekawa M; Yamamoto Y; Ishida Y; Hara H; Nakamura S; Ushiogi Y; Kawabata M; Hashimoto N
Eur J Clin Pharmacol; 1985; 28(3):327-31. PubMed ID: 2861096
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Blum RA; Kohli RK; Harrison NJ; Schentag JJ
Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
Kowalsky SF; Echols RM; Parker MA
Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
[TBL] [Abstract][Full Text] [Related]
14. [Plasma pharmacokinetics of roxatidine in the healthy man: correlation with gastric antisecretory effect].
Chen WW; Kolsky H; Lewin MJ; Bonfils S
Gastroenterol Clin Biol; 1990; 14(4):342-6. PubMed ID: 1972124
[TBL] [Abstract][Full Text] [Related]
15. Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.
Lin JH; Chremos AN; Yeh KC; Antonello J; Hessey GA
Eur J Clin Pharmacol; 1988; 34(1):41-6. PubMed ID: 2896129
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
[TBL] [Abstract][Full Text] [Related]
17. Oral flecainide pharmacokinetics in patients with impaired renal function.
Forland SC; Burgess E; Blair AD; Cutler RE; Kvam DC; Weeks CE; Fox JM; Conard GJ
J Clin Pharmacol; 1988 Mar; 28(3):259-67. PubMed ID: 3129455
[TBL] [Abstract][Full Text] [Related]
18. Disposition of minoxidil in patients with various degrees of renal function.
Halstenson CE; Opsahl JA; Wright CE; Fleishaker JC; Andreadis NA; Sobieraj J; Matzke GR
J Clin Pharmacol; 1989 Sep; 29(9):798-802. PubMed ID: 2808745
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of carumonam in patients with renal insufficiency.
Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
[TBL] [Abstract][Full Text] [Related]
20. Roxatidine acetate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic potential in peptic ulcer disease and related disorders.
Murdoch D; McTavish D
Drugs; 1991 Aug; 42(2):240-60. PubMed ID: 1717223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
